NMRD - Nemaura Medical Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/30/2019
3/30/2018
3/30/2017
3/30/2016
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
2,337
2,297
994
1,035
1,028
Selling General and Administrative
2,719
2,180
915
517
511
Total Operating Expenses
5,056
4,477
1,909
1,551
1,540
Operating Income or Loss
-5,056
-4,477
-1,909
-1,551
-1,540
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-
-
-
0
0
Income Before Tax
-5,052
-4,453
-1,820
-1,551
-1,540
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-4,438
-4,453
-1,820
-1,551
-1,540
Net Income
-4,438
-4,453
-1,820
-1,551
-1,540
Net Income available to common shareholders
-4,438
-4,453
-1,820
-1,551
-1,540
Reported EPS
Basic
-
-0.20
-0.10
-0.08
-0.08
Diluted
-
-0.20
-0.10
-0.08
-0.08
Weighted average shares outstanding
Basic
-
18,090
15,007
20,500
20,173
Diluted
-
18,090
15,007
20,500
20,173
EBITDA
-
-4,443
-1,880
-1,531
-1,522